Faes Farma, S.A. (BME:FAE)
4.390
0.00 (0.00%)
Jul 17, 2026, 5:35 PM CET
Faes Farma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 117.31 | - | 34.65 | 66.41 | 70.25 |
Short-Term Investments | 12.78 | - | - | 35.38 | - |
Cash & Short-Term Investments | 130.09 | - | 34.65 | 101.79 | 70.25 |
Cash Growth | - | - | -65.96% | 44.89% | -26.10% |
Accounts Receivable | 152.49 | - | 113.51 | 215.74 | 112.85 |
Other Receivables | 14.81 | - | - | 12.42 | - |
Total Trade Receivables | 167.3 | - | 113.51 | 228.16 | 112.85 |
Inventory | 185.01 | - | 129.03 | 115 | 107.45 |
Other Current Assets | - | - | - | 0.07 | - |
Total Current Assets | 482.4 | - | 290.29 | 313.21 | 293.71 |
Net Property, Plant & Equipment | 353.31 | 300.94 | 280.62 | 205.8 | 139.63 |
Other Intangible Assets | 199.4 | - | 184.75 | 126.91 | 182.76 |
Goodwill | 258.48 | - | - | 51.78 | - |
Long-Term Investments | 3.31 | 8.1 | 14.99 | 11.81 | 5.69 |
Other Long-Term Assets | 44.99 | - | 19.04 | 22.77 | 26.47 |
Total Assets | 1,342 | 853.08 | 776.57 | 727.15 | 645.11 |
Accounts Payable | 83.42 | 71.32 | 55.99 | 93.98 | 54.08 |
Accrued Expenses | 37.97 | - | - | 18.49 | - |
Short-Term Debt | 52.49 | - | - | 57.75 | - |
Current Portion of Long-Term Debt | - | 15.87 | - | - | - |
Current Portion of Leases | - | 2.75 | 2.23 | - | 2.1 |
Other Current Liabilities | 11 | 11.22 | 3.39 | 10.47 | 1.65 |
Total Current Liabilities | 184.88 | 103.46 | 87.3 | 94.43 | 79.31 |
Long-Term Debt | 380.8 | 2.63 | 21.9 | 8.16 | 17.12 |
Long-Term Leases | - | - | 4.37 | - | 2.15 |
Other Long-Term Liabilities | 30.63 | 17.63 | 25.27 | 22.15 | 30.67 |
Total Long-Term Liabilities | 411.43 | 23.01 | 25.86 | 30.32 | 28.46 |
Total Liabilities | 596.31 | 126.46 | 113.16 | 124.75 | 107.77 |
Common Stock | 31.62 | - | 31.62 | 62.16 | 29.74 |
Treasury Stock | -10.92 | -10.96 | -10.96 | -5.26 | -5.26 |
Additional Paid-in Capital | 1.46 | - | 1.46 | 1.46 | 1.46 |
Accumulated Other Comprehensive Income | -24.46 | -2.45 | -3.08 | -15.86 | -3.06 |
Retained Earnings | 730.8 | 706.19 | 643.38 | 579.21 | 512.93 |
Total Common Shareholders' Equity | 1,498 | 725.87 | 662.42 | 1,208 | 535.81 |
Minority Interest | 0.78 | 0.75 | 0.99 | 1.2 | 1.54 |
Shareholders' Equity | 745.59 | 726.62 | 663.41 | 602.4 | 537.35 |
Total Liabilities & Equity | 1,342 | 853.08 | 776.57 | 727.15 | 645.11 |
Total Debt | 433.29 | 21.25 | 28.51 | 65.92 | 21.36 |
Net Cash (Debt) | -303.2 | -21.25 | 6.14 | 35.87 | 48.89 |
Net Cash Growth | - | - | -82.88% | -26.63% | -36.63% |
Net Cash Per Share | -0.97 | -0.07 | 0.02 | 0.12 | 0.16 |
Book Value | 1,498 | 725.87 | 662.42 | 1,208 | 535.81 |
Book Value Per Share | 4.78 | 2.32 | 2.13 | 3.95 | 1.76 |
Tangible Book Value | 1,040 | 725.87 | 477.67 | 1,029 | 353.05 |
Tangible Book Value Per Share | 3.32 | 2.32 | 1.54 | 3.36 | 1.16 |